Day-Night Rhythm in Human Skeletal Muscle

September 4, 2015 updated by: Maastricht University Medical Center

Day-night Rhythm in Human Skeletal Muscle Metabolism

This study evaluates the existence of a day-night rhythm in skeletal muscle energy metabolism in healthy lean subjects. Subjects will stay at the research facility for 44 hours with a standardized living protocol during which several measurements of skeletal muscle and whole body energy metabolism will be performed.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Recent evidence from both observational and experimental studies indicates that disobeying our normal day-night rhythm negatively influences our metabolic and cardiovascular health, possibly leading to obesity and type 2 diabetes mellitus (T2DM). An important hallmark of obesity and T2DM is a decreased skeletal muscle mitochondrial function. Interestingly, recent research indicates that also skeletal muscle mitochondrial function under the influence of a day-night rhythm. The main objective of this study is to investigate the presence of a day-night rhythm in skeletal muscle energy metabolism (in particular mitochondrial function) of healthy young participants. Therefore, subjects will stay at the research unit for 44 hours, with standardized meals and sleeping time. During this period we will take five muscle biopsies, perform indirect calorimetry measurements and blood draws.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Maastricht, Netherlands
        • Maastricht University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Caucasian
  • Healthy (as determined by dependent physician based on medical questionnaire)
  • Male
  • Age: 18-35 years
  • Normal BMI (18-25 kg/m2)
  • Regular sleeping time (normally 7-9h daily)

Exclusion Criteria:

  • Extreme early bird or extreme night person (score ≤30 or ≥70 on MEQ-SA questionnaire)
  • Heavily varying sleep-wake rhythm
  • Shiftwork during last 3 months
  • Travel across >1 time zone in the last 3 months
  • Engagement in exercise > 2 hours total per week
  • Using >400mg caffeine daily
  • Smoking
  • Unstable body weight (weight gain or loss > 3kg in the last 3 months)
  • Significant food allergies/intolerance (seriously hampering study meals)
  • Participation in another biomedical study within 1 month before the first study visit
  • Any contra-indication to Magnetic Resonance Imaging (MRI) scanning

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Standardized living protocol
Subjects are kept at the research facility to adhere to a standardized living protocol, mimicking a normal daily living situation. During the study, multiple tests will be performed, including muscle biopsies, blood draws, MRS measurements and indirect calorimetry.
Subjects stay at the research facility for 44 hours and adhere to a standard sleeping, eating and activity protocol. During this protocol, multiple measurements will be performed including skeletal muscle biopsies (m. vastus lateralis), blood draws, indirect calorimetry and MRS measurements.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Day-night rhythm in skeletal muscle mitochondrial respiration
Time Frame: 40 hours.
O2-flux (pmol/mg/s) measured with high resolution respirometry upon administration of different substrates
40 hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Day-night rhythm in whole-body energy metabolism
Time Frame: 40 hours.
Energy expenditure (kJ/min), glucose oxidation (g/min) and fat oxidation (g/min) measured by indirect calorimetry
40 hours.
Day-night rhythm in muscle DNA, mRNA and protein levels of markers involved in molecular clock and mitochondrial metabolism.
Time Frame: 40 hours.
Quantify mRNA and protein levels by qPCR or micro-array and Western blots
40 hours.
Day-night rhythm of in markers of normal day-night rhythm (cortisol, melatonin, core body temperature)
Time Frame: measured during the 2nd study day
Blood cortisol and melatonin levels and core body temperature measured by an ingested telemetric pill.
measured during the 2nd study day
Day-night rhythm in blood metabolic compounds (e.g. glucose, insulin, FFA's, cholesterol)
Time Frame: measured during the 2nd study day
measured during the 2nd study day
Day-night rhythm of molecular clock mRNA and protein levels in blood PBMC's
Time Frame: measured during the 2nd study day
Measured by qPCR and Western Blots
measured during the 2nd study day
Change in liver volume and liver lipid concentration during the day
Time Frame: First study day 6 PM, second study day 7 AM
Measured by Magnetic Resonance Imaging and -Spectroscopy (MRI/MRS). Lipid signals in the MRS spectra will be quantified while suppressing the strong water signal in the region of interest (right liver lobe)
First study day 6 PM, second study day 7 AM

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patrick Schrauwen, PhD, Professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Actual)

July 1, 2015

Study Completion (Actual)

July 1, 2015

Study Registration Dates

First Submitted

September 24, 2014

First Submitted That Met QC Criteria

October 6, 2014

First Posted (Estimate)

October 10, 2014

Study Record Updates

Last Update Posted (Estimate)

September 7, 2015

Last Update Submitted That Met QC Criteria

September 4, 2015

Last Verified

September 1, 2015

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • METC143027
  • NL49363.068.14 (Registry Identifier: Toetsing Online)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on Standardized living protocol

3
Subscribe